ET, G., AP, C., CL, J., D, R., M, S., KE, R., . . . ET, M. (2025). Respiratory syncytial virus (RSV) vaccine effectiveness and antibody correlates of protection among older adults in the Community Vaccine Effectiveness (CoVE) observational study. EBioMedicine, 121, 105961. https://doi.org/10.1016/j.ebiom.2025.105961
Chicago Style (17th ed.) CitationET, Godonou, et al. "Respiratory Syncytial Virus (RSV) Vaccine Effectiveness and Antibody Correlates of Protection Among Older Adults in the Community Vaccine Effectiveness (CoVE) Observational Study." EBioMedicine 121 (2025): 105961. https://doi.org/10.1016/j.ebiom.2025.105961.
MLA (9th ed.) CitationET, Godonou, et al. "Respiratory Syncytial Virus (RSV) Vaccine Effectiveness and Antibody Correlates of Protection Among Older Adults in the Community Vaccine Effectiveness (CoVE) Observational Study." EBioMedicine, vol. 121, 2025, p. 105961, https://doi.org/10.1016/j.ebiom.2025.105961.